封面
市場調查報告書
商品編碼
1529563

戒菸和尼古丁成癮預防產品市場:按給藥途徑、按產品、按分銷管道、按地區

Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, By Product, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 358 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計2024年全球戒菸和尼古丁成癮產品市場價值為165.5億美元,預計到2031年將達到501億美元,2024年至2031年的複合年成長率為17.1%。

報告範圍 報告詳情
基準年 2023年 2024年市場規模 165.5億美元
實際資料 2019-2023 預測期 2024-2031
2024-2031 年預測期複合年成長率 17.10% 2031 年金額預測 501億美元
圖:戒菸和尼古丁成癮預防產品的市場佔有率(%)(2024年,按地區)
戒菸及尼古丁戒菸產品市場-IMG1

由於世界吸菸人口的增加以及人們對吸菸造成的健康風險的認知不斷增強,戒菸和尼古丁成癮預防產品的全球市場正在經歷顯著成長。吸菸已成為全球公共衛生問題,世界衛生組織(WHO)建議採取多種措施幫助人們戒菸。尼古丁替代療法和其他戒煙輔助劑已被證明可以有效幫助吸菸者戒菸。一些政府和非政府組織的宣傳宣傳活動正在推動對尼古丁口香糖、貼片、含片和戒菸處方藥的需求。產品配方和新技術的進步正在擴大想要戒菸的吸菸者的選擇。然而,某些戒菸產品的高成本和菸癮的持續存在給產業帶來了挑戰。

市場動態:

全球戒菸和尼古丁成癮預防產品市場的成長是由吸菸相關疾病的日益流行、消費者健康意識的提高以及公共機構遏制菸草使用的各種舉措所推動的。然而,某些戒菸治療的高成本以及菸草業反對產品監管的強烈遊說正在限制市場成長。戒菸治療數位解決方案的激增正在開闢新的機會。人們已經開發了各種行動應用程式和線上程序,以提高尼古丁替代療法和消費者行為支援的有效性。尼古丁替代輸送形式的創新也是一個受到關注的關鍵趨勢。

本研究的主要特點

  • 本報告對全球戒菸和尼古丁成癮預防產品市場進行了詳細分析,並提出了以2023年為基礎的預測期(2024-2031)的市場規模(十億美元)和年複合成長率(CAGR%)年。 %)發布。
  • 它還揭示了各個細分市場的潛在商機,並說明了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要見解。
  • 根據公司亮點、產品系列、主要亮點、績效和策略等參數,提供全球戒菸和尼古丁成癮預防產品市場主要企業的概況。
  • 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
  • 全球戒菸和尼古丁成癮產品市場報告針對該行業的各個相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 相關人員可以透過全球戒菸和尼古丁成癮產品市場分析中使用的各種策略矩陣來促進他們的決策。

目錄

第1章 研究目的與前提

  • 研究目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行概述
  • 一致的機會地圖 (COM)

第3章 市場動態、法規與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會
  • 影響分析
  • 市場趨勢
  • 監管場景
  • 收購和合作場景
  • 資金籌措和投資
  • PEST分析
  • 波特的分析

第4章全球戒菸和尼古丁成癮產品市場 - 冠狀病毒(COVID-19)大流行的影響

  • 整體影響
  • 政府舉措
  • COVID-19 對市場的影響

第5章 2019-2031 年全球戒菸和尼古丁成癮預防產品市場(途徑)(十億美元)

  • 介紹
  • 口服
  • 經皮的
  • 鼻腔
  • 舌下給藥

第6章 2019-2031 年全球戒菸與尼古丁成癮預防產品市場(分產品)(十億美元)

  • 介紹
  • 尼古丁替代療法
  • 尼古丁噴霧
  • 尼古丁吸入器
  • 尼古丁口香糖
  • 尼古丁經皮吸收貼片
  • 尼古丁舌下含片
  • 尼古丁含片
  • 藥物治療
  • Varenicline
  • Zyban
  • 尼可萊特頰
  • 電子煙/煙油

第7章 2019-2031 年全球吸菸與尼古丁成癮產品市場(按通路分類)(十億美元)

  • 介紹
  • 醫院藥房
  • 網路藥房
  • 零售藥房

第8章 2019-2031 年全球吸菸與尼古丁成癮產品市場(按地區)(十億美元)

  • 介紹
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東

第9章 競爭格局

  • 公司簡介
    • GlaxoSmithKline plc(GSK)
    • Pfizer Inc.
    • Johnson &Johnson
    • Novartis International AG
    • Imperial Brands plc
    • British American Tobacco plc(BAT)
    • Cipla Inc.
    • McNeil AB
    • NJOY, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Perrigo Company plc
    • Fertin Pharma
    • Philip Morris International Inc.
    • Alkalon A/S
    • Japan Tobacco Inc.
    • Nicotek, LLC
    • 22nd Century Group Inc.

第10章分析師建議

  • 上升和下降
  • 綜合機會圖

第11章 參考文獻與調查方法

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI134

The Global Smoking Cessation and Nicotine De-addiction Products Market is estimated to be valued at USD 16.55 Bn in 2024 and is expected to reach USD 50.10 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 17.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 16.55 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 17.10% 2031 Value Projection: US$ 50.10 Bn
Figure. Smoking Cessation and Nicotine De-addiction Products Market Share (%), By Region 2024
Smoking Cessation and Nicotine De-addiction Products Market - IMG1

The global market for smoking cessation and nicotine de-addiction products is growing significantly owing to the rising global population of smokers and increasing awareness about health hazards of smoking. Smoking has become a worldwide public health issue and the World Health Organization (WHO) recommends various measures to help people quit tobacco consumption. Nicotine replacement therapies and other smoking cessation aids are proving effective in assisting smokers to break the habit. Several awareness campaigns by governments and NGOs have boosted the demand for nicotine gums, patches, lozenges and prescription medications for quitting smoking. Advancements in product formulations and newer technologies are expanding the choices available to smokers who want to quit. However, high prices of certain de-addiction products and persistence of tobacco addiction pose challenges to the industry.

Market Dynamics:

The global smoking cessation and nicotine de-addiction products market growth is driven by the increasing prevalence of smoking-related diseases, growing health consciousness among consumers, and various initiatives by public organizations to curb tobacco use. However, high costs of certain smoking cessation therapies, along with strong tobacco industry lobbying against product regulations, are restraining the market growth. The widespread adoption of digital solutions for smoking cessation therapies is opening new opportunities. Various mobile apps and online programs are being developed to improve the effectiveness of nicotine replacement therapies and behavioral support for consumers. Innovation in alternate delivery forms of nicotine is another key trend gaining traction.

Key Features of the Study:

  • This report provides in-depth analysis of the global smoking cessation and nicotine de-addiction products market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global smoking cessation and nicotine de-addiction products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline, Pfizer, Johnson & Johnson, and Dr. Reddy's Laboratories
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global smoking cessation and nicotine de-addiction products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global smoking cessation and nicotine de-addiction products market.

Detailed Segmentation-

  • By Route of Administration
    • Oral
    • Transdermal
    • Nasal
    • Sublingual
    • Oral
  • By Product
    • Nicotine Replacement Therapy
    • Nicotine Spray
    • Nicotine Inhalers
    • Nicotine Gum
    • Nicotine Transdermal Patches
    • Nicotine Sublingual Tablets
    • Nicotine Lozenges
    • Drug Therapy
    • Varenicline
    • Zyban
    • Nicorette Buccal
    • E-cigarettes/E-liquid
  • By Distribution Channel
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • GlaxoSmithKline plc (GSK)
    • Pfizer Inc.
    • Johnson & Johnson
    • Novartis International AG
    • Imperial Brands plc
    • British American Tobacco plc (BAT)
    • Cipla Inc.
    • McNeil AB
    • NJOY, Inc.
    • Reddy's Laboratories Ltd.
    • Perrigo Company plc
    • Fertin Pharma
    • Philip Morris International Inc.
    • Alkalon A/S
    • Japan Tobacco Inc.
    • Nicotek, LLC
    • 22nd Century Group Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Product
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Smoking Cessation and Nicotine De-addiction Products Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Smoking Cessation and Nicotine De-addiction Products Market, By Route of Administration, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Transdermal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nasal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Sublingual
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Smoking Cessation and Nicotine De-addiction Products Market, By Product, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Nicotine Replacement Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Spray
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Inhalers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Gum
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Transdermal Patches
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Sublingual Tablets
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicotine Lozenges
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Drug Therapy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Varenicline
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Zyban
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Nicorette Buccal
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • E-cigarettes/E-liquid
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Smoking Cessation and Nicotine De-addiction Products Market, By Distribution Channel, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Hospital Pharmacy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Online Pharmacy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Retail Pharmacy
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Smoking Cessation and Nicotine De-addiction Products Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • GlaxoSmithKline plc (GSK)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pfizer Inc.
    • Johnson & Johnson
    • Novartis International AG
    • Imperial Brands plc
    • British American Tobacco plc (BAT)
    • Cipla Inc.
    • McNeil AB
    • NJOY, Inc.
    • Dr. Reddy's Laboratories Ltd.
    • Perrigo Company plc
    • Fertin Pharma
    • Philip Morris International Inc.
    • Alkalon A/S
    • Japan Tobacco Inc.
    • Nicotek, LLC
    • 22nd Century Group Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact